Wed. 1 May 2024, 7:02am ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.04) by 75 percent. This is a 75 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $63.474 million which beat the analyst consensus estimate of $54.579 million by 16.30 percent. This is a 713.46 percent increase over sales of $7.803 million the same period last year.